AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10480522 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg/day)
Number of subjects: 9
Study 10480522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 8761775 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 p. 100 adapalene gel
Number of subjects: 89
Study 8761775 — intervention group
Group type: COMPARATOR
Intervention: 0.03 p. 100 adapalene gel
Number of subjects: 89
Study 8761775 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025 p. 100 tretinoin gel
Number of subjects: 89
Study 2116634 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help smoking cessation program (printed materials received through the mail)
Number of subjects: 100
Study 2116634 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 100
Study 6118121 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg atenolol for 3 days
Number of subjects: 40
Study 6118121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 6118121 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenethylline-hydrochloride, diazepam, oxazepam, and alcohol
Number of subjects: 40
Study 31731134 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefabricated foot orthoses
Number of subjects: 21
Study 31731134 — intervention group
Group type: COMPARATOR
Intervention: Flat shoe inserts
Number of subjects: 21
Study 31731134 — intervention group
Group type: COMPARATOR
Intervention: Own shoes
Number of subjects: 21
Study 31752771 — intervention group
Group type: EXPERIMENTAL
Intervention: MBM intervention (mobile phone application for women and clinician education)
Number of subjects: 256700
Study 31752771 — intervention group
Group type: EXPERIMENTAL
Intervention: MBM intervention
Number of subjects: 256700
Study 28679413 — intervention group
Group type: EXPERIMENTAL
Intervention: Double carbapenem (DC) regimen
Number of subjects: 144
Study 28679413 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (ST)
Number of subjects: 144
Study 26040181 — intervention group
Group type: COMPARATOR
Intervention: LASIK treatment
Number of subjects: 68
Study 26040181 — intervention group
Group type: EXPERIMENTAL
Intervention: PRK treatment
Number of subjects: 68
Study 25099185 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (1000 mg, once daily) and prednisolone (5 mg, twice daily)
Number of subjects: 82
Study 25099185 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate and prednisolone
Number of subjects: 82
Study 22965975 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Treatment (MT)
Number of subjects: 611
Study 22965975 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 611
Study 22965975 — intervention group
Group type: COMPARATOR
Intervention: Coronary Artery Bypass Graft (CABG)
Number of subjects: 611
Study 19442491 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate discontinuation of current antipsychotic with aripiprazole (10 mg)
Number of subjects: 77
Study 19442491 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering off current antipsychotic over 4 weeks with aripiprazole (10 mg)
Number of subjects: 77
Study 19442491 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering off current antipsychotic over 6 weeks with aripiprazole (10 mg)
Number of subjects: 77
Study 19442491 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 77
Study 17880369 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 g agar
Number of subjects: 10
Study 17880369 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.2 g pectin
Number of subjects: 10
Study 17880369 — intervention group
Group type: COMPARATOR
Intervention: Control meal (fibre-free meal)
Number of subjects: 10
Study 15336581 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician reminders recommending documentation of advance directives
Number of subjects: 1079
Study 15336581 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician reminders plus mailing advance directives to patients with educational literature
Number of subjects: 1079
Study 15336581 — intervention group
Group type: COMPARATOR
Intervention: Control group (neither intervention)
Number of subjects: 1079
Study 11257337 — intervention group
Group type: COMPARATOR
Intervention: CAIV-T vaccine
Number of subjects: 6163
Study 9557039 — intervention group
Group type: EXPERIMENTAL
Intervention: Tesio catheter (TC) for long-term hemodialysis
Number of subjects: 26
Study 7738212 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 19
Study 7738212 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 19
Study 7738212 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 19
Study 7738212 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide
Number of subjects: 19
Study 7738212 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 19
Study 7738212 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 19
Study 2563000 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorionic villus sampling (CVS)
Number of subjects: 2787
Study 2563000 — intervention group
Group type: COMPARATOR
Intervention: Amniocentesis
Number of subjects: 2787
Study 387824 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ppm formaldehyde solution applied in an axilla for 2 weeks (double-blind controlled test)
Number of subjects: 13
Study 387824 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed patch test with 30 ppm formaldehyde for 120 continuous hours
Number of subjects: 13
Study 31958404 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-component intervention package (refresher training for providers, counselling tool, supportive supervision, daily availability of contraceptive services, client appointment cards, invitation letters for partners)
Number of subjects: 576
Study 31958404 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal and postnatal care (control group)
Number of subjects: 576
Study 31958404 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-component intervention package
Number of subjects: 576
Study 31729989 — intervention group
Group type: EXPERIMENTAL
Intervention: IWB/CRL + CM
Number of subjects: 80
Study 31729989 — intervention group
Group type: COMPARATOR
Intervention: CM-only
Number of subjects: 80
Study 27469421 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal support lifestyle education programme (PSMetS)
Number of subjects: 193
Study 27469421 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 193
Study 25881802 — intervention group
Group type: EXPERIMENTAL
Intervention: Early corticosteroid withdrawal (CSWD)
Number of subjects: 0
Study 25881802 — intervention group
Group type: COMPARATOR
Intervention: Chronic corticosteroids (CCS)
Number of subjects: 0
Study 24202191 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoked cannabis joint (11% Δ9-THC)
Number of subjects: 0
Study 24202191 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0
Study 24202191 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular smokers
Number of subjects: 0
Study 22324182 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic-psychomotor family counselling (PsyFam; based on symbolic play)
Number of subjects: 0
Study 22324182 — intervention group
Group type: COMPARATOR
Intervention: Systemic family therapy (SB; exclusively verbal)
Number of subjects: 0
Study 19415994 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT(4)) treatment in OH group
Number of subjects: 103
Study 19415994 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT(4)) treatment in SH group
Number of subjects: 103
Study 19415994 — intervention group
Group type: COMPARATOR
Intervention: Control group (EU women)
Number of subjects: 103
Study 17059616 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia with local anaesthetic infiltration
Number of subjects: 0
Study 17059616 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia with placebo infiltration
Number of subjects: 0
Study 15936120 — intervention group
Group type: EXPERIMENTAL
Intervention: OPV produced on MRC-5 cells
Number of subjects: 0
Study 15936120 — intervention group
Group type: COMPARATOR
Intervention: OPV produced on PMKC cells
Number of subjects: 0
Study 14640854 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive function assessment at 6 days post-surgery
Number of subjects: 107
Study 14640854 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive function assessment at 8 weeks post-surgery
Number of subjects: 107
Study 14640854 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive function assessment at 5 years post-surgery
Number of subjects: 107
Study 14640854 — intervention group
Group type: EXPERIMENTAL
Intervention: Microemboli recorded during surgery
Number of subjects: 107
Study 14640854 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative short-term cognitive change
Number of subjects: 107
Study 14640854 — intervention group
Group type: EXPERIMENTAL
Intervention: Degree of recovery at 8 weeks
Number of subjects: 107
Study 10921125 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence capsule
Number of subjects: 435
Study 10921125 — intervention group
Group type: COMPARATOR
Intervention: Lofexidine
Number of subjects: 435
Study 7791587 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation at 20% of maximum voluntary isometric contraction (MVC)
Number of subjects: 50
Study 7791587 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation at 50% of maximum voluntary isometric contraction (MVC)
Number of subjects: 50
Study 7791587 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation at 80% of maximum voluntary isometric contraction (MVC)
Number of subjects: 50
Study 7791587 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically elicited fatigue tests at 20 pps with 20% MVC
Number of subjects: 50
Study 7791587 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically elicited fatigue tests at 40 pps with 20% MVC
Number of subjects: 50
Study 7791587 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically elicited fatigue tests at 60 pps with 20% MVC
Number of subjects: 50
Study 7791587 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically elicited fatigue tests at 20 pps with 50% MVC
Number of subjects: 50
Study 7791587 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically elicited fatigue tests at 40 pps with 50% MVC
Number of subjects: 50
Study 7791587 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically elicited fatigue tests at 60 pps with 50% MVC
Number of subjects: 50
Study 1828417 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 0
Study 1828417 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazide diuretics
Number of subjects: 0
Study 1828417 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibitors
Number of subjects: 0
Study 1828417 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca2(+)‐channel blockers
Number of subjects: 0
Study 1828417 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-blockers
Number of subjects: 0
Study 6782486 — intervention group
Group type: EXPERIMENTAL
Intervention: trimethoprim‐sulfamethoxazole plus nystatin
Number of subjects: 53
Study 6782486 — intervention group
Group type: COMPARATOR
Intervention: gentamicin plus nystatin
Number of subjects: 53
Study 29703432 — intervention group
Group type: EXPERIMENTAL
Intervention: Elbasvir 50 mg once daily for 5 days
Number of subjects: 0
Study 29703432 — intervention group
Group type: EXPERIMENTAL
Intervention: Grazoprevir 100 mg once daily for 7 days
Number of subjects: 0
Study 27044249 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathlessness Intervention Service (BIS)
Number of subjects: 87
Study 27044249 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 87
Study 23996473 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intravenous (iv) doses of blosozumab up to 750 mg
Number of subjects: 12
Study 23996473 — intervention group
Group type: EXPERIMENTAL
Intervention: Single subcutaneous (sc) doses of blosozumab 150 mg
Number of subjects: 12
Study 23996473 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple iv doses of blosozumab up to 750 mg every 2 weeks for 8 weeks
Number of subjects: 12
Study 23996473 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple sc doses of blosozumab up to 270 mg every 2 weeks for 8 weeks
Number of subjects: 12
Study 23996473 — intervention group
Group type: EXPERIMENTAL
Intervention: Blosozumab (single or multiple administrations)
Number of subjects: 12
Study 23996473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 22024822 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous doxycycline (40 to 200 mg)
Number of subjects: 14
Study 22024822 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral doxycycline (40 to 200 mg daily)
Number of subjects: 14
Study 22024822 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (oral administration)
Number of subjects: 14
Study 22024822 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (intravenous and oral)
Number of subjects: 14
Study 20716558 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) alone
Number of subjects: 418
Study 20716558 — intervention group
Group type: COMPARATOR
Intervention: Combination of clomiphene citrate (CC) plus metformin
Number of subjects: 418
Study 18455526 — intervention group
Group type: EXPERIMENTAL
Intervention: Active management of risk in pregnancy at term (AMOR‐IPAT)
Number of subjects: 270
Study 16207699 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition supplement administered by nursing staff, aiming to meet 45% of estimated energy requirements, starting on day 7 for 42 days
Number of subjects: 49
Study 16207699 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition supplement for 'nonrefusers' (n = 35)
Number of subjects: 49
Study 16207699 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition supplement for 'refusers' (n = 14, 29%)
Number of subjects: 49
Study 12006122 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposterolic extract of Serenoa repens (LSESr) and beta-sitosterol
Number of subjects: 10
Study 12006122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 10071274 — intervention group
Group type: EXPERIMENTAL
Intervention: VCP (vincristine, lomustine, and prednisone) after XRT
Number of subjects: 203
Study 10071274 — intervention group
Group type: COMPARATOR
Intervention: 8-in-1 chemotherapy before and after XRT
Number of subjects: 203
Study 10071274 — intervention group
Group type: EXPERIMENTAL
Intervention: Children aged 1.5 to younger than 3 years
Number of subjects: 203
Study 10071274 — intervention group
Group type: EXPERIMENTAL
Intervention: Children aged 3 years or older
Number of subjects: 203
Study 10071274 — intervention group
Group type: EXPERIMENTAL
Intervention: M0 tumors with < or = 1.5 cm2 of residual tumor
Number of subjects: 203
Study 10071274 — intervention group
Group type: EXPERIMENTAL
Intervention: M0 tumors with > or = 1.5 cm2 of residual tumor
Number of subjects: 203
Study 10071274 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor spread (MO vs M1 vs M2+) for patients 3 years of age or older
Number of subjects: 203
Study 7570323 — intervention group
Group type: EXPERIMENTAL
Intervention: OLT candidates after volume infusion (1 L of crystalloid)
Number of subjects: 25
Study 7570323 — intervention group
Group type: COMPARATOR
Intervention: Controls (normal liver function)
Number of subjects: 25
Study 7570323 — intervention group
Group type: EXPERIMENTAL
Intervention: PFI (portal flow index) as a predictor
Number of subjects: 25
Study 2111786 — intervention group
Group type: EXPERIMENTAL
Intervention: Enprostil (70 micrograms)
Number of subjects: 8
Study 2111786 — intervention group
Group type: COMPARATOR
Intervention: Control (vehicle)
Number of subjects: 8
Study 6794821 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotonic (0.3%) saline
Number of subjects: 19
Study 6794821 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic (2.7%, 3.6%) saline
Number of subjects: 19
Study 6794821 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic (0.9%) saline
Number of subjects: 19
Study 6794821 — intervention group
Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 19
Study 6794821 — intervention group
Group type: COMPARATOR
Intervention: 3.6% saline
Number of subjects: 19
Study 31615540 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including provider training (in-person seminar, online course, management algorithms, prescribing feedback) and an information booklet for families
Number of subjects: 410
Study 31615540 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 410
Study 28189180 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive RBC transfusion practices
Number of subjects: 0
Study 28189180 — intervention group
Group type: COMPARATOR
Intervention: Liberal RBC transfusion practices
Number of subjects: 0
Study 24531439 — intervention group
Group type: EXPERIMENTAL
Intervention: Peristaltic pulse dynamic compression (PPDC) treatment for 15 minutes on both legs using computer-controlled circumferential inflated leggings.
Number of subjects: 24
Study 24531439 — intervention group
Group type: COMPARATOR
Intervention: Control group with the same procedures as the experimental group but with the inflation pump turned off.
Number of subjects: 24
Study 23567095 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 450
Study 23567095 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy
Number of subjects: 450
Study 23567095 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 450
Study 21750137 — intervention group
Group type: EXPERIMENTAL
Intervention: High-concentration contrast medium (HCCM) during scheme B (fixed injection flow rate 4 ml s(‐1))
Number of subjects: 30
Study 21750137 — intervention group
Group type: COMPARATOR
Intervention: Moderate-concentration contrast medium (MCCM) during scheme B (fixed injection flow rate 4 ml s(‐1))
Number of subjects: 30
Study 21750137 — intervention group
Group type: EXPERIMENTAL
Intervention: High-concentration contrast medium (HCCM) during scheme A (fixed injection duration 25 s)
Number of subjects: 30
Study 21750137 — intervention group
Group type: COMPARATOR
Intervention: Moderate-concentration contrast medium (MCCM) during scheme A (fixed injection duration 25 s)
Number of subjects: 30
Study 19800914 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing conservation program including classroom instruction, distribution of hearing protection devices, direct mailings, noise level assessments, and yearly audiometric testing
Number of subjects: 753
Study 19800914 — intervention group
Group type: COMPARATOR
Intervention: Control group received audiometric testing only
Number of subjects: 753
Study 16965196 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting risperidone 25 mg
Number of subjects: 324
Study 16965196 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting risperidone 50 mg
Number of subjects: 324
Study 16965196 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting risperidone 25 mg and 50 mg
Number of subjects: 324
Study 12709266 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 10800812 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 40
Study 10800812 — intervention group
Group type: COMPARATOR
Intervention: Conventional CABG
Number of subjects: 40
Study 8986186 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular tenoxicam 20 mg in 20 ml of normal saline
Number of subjects: 60
Study 8986186 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tenoxicam 20 mg in 2 ml
Number of subjects: 60
Study 1635724 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwifery management
Number of subjects: 492
Study 1635724 — intervention group
Group type: COMPARATOR
Intervention: Physician management
Number of subjects: 492
Study 6434058 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care by hospital diabetic clinic
Number of subjects: 200
Study 6434058 — intervention group
Group type: COMPARATOR
Intervention: Routine care in general practice
Number of subjects: 200
Study 31950038 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-segment instrumentation with augmentation by screws and bone substitutes
Number of subjects: 42
Study 31950038 — intervention group
Group type: COMPARATOR
Intervention: Long-segment instrumentation without vertebra augmentation
Number of subjects: 42
Study 27432441 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioural Therapy (CBT)
Number of subjects: 0
Study 27432441 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 0
Study 26516999 — intervention group
Group type: EXPERIMENTAL
Intervention: Popliteal block
Number of subjects: 51
Study 26516999 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 51
Study 23489210 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg zanamivir
Number of subjects: 30
Study 23489210 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg zanamivir
Number of subjects: 30
Study 23489210 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg zanamivir
Number of subjects: 30
Study 23489210 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg zanamivir (5-day BID)
Number of subjects: 30
Study 23489210 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 21527004 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser biopsy
Number of subjects: 442
Study 21527004 — intervention group
Group type: COMPARATOR
Intervention: Acid Tyrode biopsy
Number of subjects: 442
Study 19562574 — intervention group
Group type: EXPERIMENTAL
Intervention: 32 g liquorice alone for 2 weeks
Number of subjects: 10
Study 19562574 — intervention group
Group type: EXPERIMENTAL
Intervention: 32 g liquorice combined with 25 mg hydrochlorothiazide for 2 weeks
Number of subjects: 10
Study 17113896 — intervention group
Group type: EXPERIMENTAL
Intervention: Information about the detection rate
Number of subjects: 137
Study 17113896 — intervention group
Group type: COMPARATOR
Intervention: Additional information about the failure to demonstrate the mortality-reducing effect of prostate-specific antigen screening
Number of subjects: 137